Akèy › Myelofibroz › New York › New York City
Etid klinik pou Myelofibroz nan New York City, NY
18 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Ap rekriteFaz 1/2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ap rekriteFaz 2
- NYP/Weill Cornell Medical Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Ap rekriteFaz 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Icahn School of Medicine At Mount Sinai, New York
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Ap rekriteFaz 2
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Ap rekriteFaz 2
- GSK Investigational Site, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- Memorial Sloan Kettering, New York
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Ap rekriteFaz 2
- Weill Cornell Medicine NewYork-Presbyterian, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Ap rekriteFaz 2
- Ruttenberg Treatment Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, New York
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Ap rekriteFaz 3
- ICAHN School of Medicine at Mount Sinai, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Ap rekriteFaz 1
- Columbia University, New York
Etid Myelofibroz nan lòt vil
- Houston, TX19 etid
- Boston, MA12 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- Columbus, OH11 etid
- Miami, FL10 etid
- Salt Lake City, UT10 etid
- Nashville, TN9 etid
- Baldwin Park, CA9 etid
- Atlanta, GA9 etid
- Tampa, FL9 etid
- Cleveland, OH9 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.